An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes (EU-CAPTURE)

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT03786406

NN2211-4423

U1111-1207-2816 (Other Identifier)

Details and patient eligibility

About

The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes (T2DM) patients across five selected countries in Europe. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than what has been prescribed to them by their doctor. Participants' participation will be one day/one visit at study doctor. The study will last for about 3 months in total.

Enrollment: 2,275 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to protocol)
• Male or female, age greater than or equal to 18 years at the time of signing informed consent
• Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days prior to the day of signing the informed consent

Exclusion criteria

• Previous participation in this study. Participation is defined as having given informed consent in this study
• Diagnosed with Type 1 diabetes
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• Patients with known congenital heart disease/malformation

Trial design

2,275 participants in 1 patient group

T2DM patients seen in routine practice

Description:

All anti-diabetic and cardiovascular (CV) medication will be prescribed at the physician's discretion under routine clinical practice conditions.

Treatment:

Other: No treatment given